Compare LABT & STKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LABT | STKH |
|---|---|---|
| Founded | 2006 | 2018 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 670.6K | 566.1K |
| IPO Year | 2026 | 2020 |
| Metric | LABT | STKH |
|---|---|---|
| Price | $0.20 | $0.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | 607.7K | ★ 1.0M |
| Earning Date | 11-18-2026 | 08-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $218.44 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $0.30 |
| 52 Week High | $6.85 | $7.10 |
| Indicator | LABT | STKH |
|---|---|---|
| Relative Strength Index (RSI) | 16.87 | 25.32 |
| Support Level | N/A | $0.36 |
| Resistance Level | $2.13 | $0.64 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 1.52 | 32.41 |
Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.
Steakholder Foods Ltd is engaged in transforming the alternative protein industry through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures, such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.